Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation

References

• Aiges HW, Daum F, Olson M, Kahn E, Teichberg S. (1980). The effects of phenobarbital and diphenylhydantoin on liver function and morphology. J Pediatr 97:22–6.
   PubMedGoogle Scholar
• Al Kholaifi A, Amer A, Jeffery B, Gray TJB, Roberts RA, Bell DB. (2008). Species-specific kinetics and zonation of hepatic DNA synthesis induced by ligands of PPARα. Toxicol Sci 104:74–85.
   PubMedGoogle Scholar
• Ashby J, Brady A, Elcombe CR, Elliott BM, Ishmael J, Odum J, Tugwood JD, Kettle S, Purchase IFH. (1994) Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum Exptl Toxicol 13 (Suppl. 2):S1–S117.
   Google Scholar
• Baker TK, Bachowski S, Stevenson DE, Walborg EF Jr, Klaunig JE. (1995). Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocytes by non-genotoxic compounds. Prog Clin Biol Res 391:71–80.
   PubMedGoogle Scholar
• Barrass NC, Price RJ, Lake BG, Orton TC. (1993) Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis 14:1451–6.
   PubMed Web of Science ®Google Scholar
• Bars RG, Mitchell AM, Wolf CR, Elcombe CR. (1989). Induction of cytochrome P-450 in cultured rat hepatocytes. The heterogeneous localization of specific isoenzymes using immunocytochemistry. Biochem J 262:151–8.
   PubMed Web of Science ®Google Scholar
• Bell DR, Bars RG, Gibson GG, Elcombe CR. (1991). Localization and differential induction of cytochrome P450IVA and acyl-CoA oxidase in rat liver. Biochem J 275:247–52.
   PubMed Web of Science ®Google Scholar
• Bentley P, Calder I, Elcombe C, Grasso P, Stringer D, Wiegand H-J. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem Toxicol 31:857–907.
   PubMed Web of Science ®Google Scholar
• Bichet N, Cahard D, Fabre G, Remandet B, Gouy D, Cano JP. (1990). Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture. Toxicol Appl Pharmacol 106:509–17.
   PubMedGoogle Scholar
• Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36:781–92.
   PubMed Web of Science ®Google Scholar
• Bursch W, Chabicovsky M, Wastl U, Grasl-Kraupp B, Bukowska K, Taper H, Schulte-Hermann R. (2005b). Apoptosis in early stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility. Toxicol Sci 85:515–29.
   PubMed Web of Science ®Google Scholar
• Bursch W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, Schulte-Hermann R. (1984). Controlling death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5:453–8.
   PubMed Web of Science ®Google Scholar
• Bursch W, Wastl U, Hufnagl K, Schulte-Hermann R. (2005a). No increase in apoptosis in regressing mouse liver after withdrawal of growth stimuli or food restriction. Toxicol Sci 85:507–14.
   PubMed Web of Science ®Google Scholar
• Butterworth BE, Smith-Oliver T, Earle L, Loury DJ, White RD, Doolittle DJ, Working PK, Cattley RC, Jirtle R, Michalopoulos G, Strom S. (1989). Use of primary cultures of human hepatocytes in toxicology studies. Cancer Res 49:1075–84.
   PubMed Web of Science ®Google Scholar
• Cariello NF, Romach EH, Colton HM, Ni H, Yoon L, Falls JG, Casey W, Creech D, Anderson SP, Benavides GR, Hoivik DJ, Brown R, Miller RT. (2005). Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the Cynomolgus monkey liver. Toxicol Sci 88:250–64.
   PubMed Web of Science ®Google Scholar
• Carthew P, Edwards RE, Nolan BM. (1998). The quantitative distinction of hyperplasia from hypertrophy in hepatomegaly in the rat liver by phenobarbital. Toxicol Sci 44:46–51.
   PubMed Web of Science ®Google Scholar
• Carthew P, Maronpot RR, Foley JF, Edwards RE, Nolan BM. (1997). Method for determining whether the number of hepatocytes in rat liver is increased after treatment with the peroxisome proliferator gemfibrozil. J Appl Toxicol 17:47–51.
   PubMedGoogle Scholar
• Cheung C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ. (2004). Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator- activated receptor-α. Cancer Res 64:3849–54.
   PubMed Web of Science ®Google Scholar
• Chiang JY, Steggles AW. (1983). Identification and partial purification of hamster microsomal cytochrome P-450 isoenzymes. Biochem Phamacol 32:1389–97.
   PubMed Web of Science ®Google Scholar
• Chipman JK, Mally A, Edwards GO. (2003). Disruption of gap junctions in toxicity and carcinogenicity. Toxicol Sci 71:146–53.
   PubMed Web of Science ®Google Scholar
• Choudhury AI, Chahal S., Bell AR, Tomlinson SR, Roberts RA, Salter AM, Bell DR. (2000). Species differences in peroxisome proliferation: mechanisms and relevance. Mutat Res 448:201–12.
   PubMed Web of Science ®Google Scholar
• Choudhury AI, Sims HM, Horley NJ, Roberts RA, Tomlinson SR, Salter AM, Bruce M, Shaw PN, Kendall D, Barrett DA, Bell DR. (2004). Molecular analysis of peroxisome proliferation in the hamster. Toxicol Appl Pharmacol 197:9–18.
   PubMedGoogle Scholar
• Cohen SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow DG, Seed J, Dellarco V, Fenner-Crisp P, Patton D. (2004). Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci 78:181–6.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Meek ME, Klaunig JE, Patton DE, Fenner-Crisp PA. (2003). The human relevance of information on carcinogenic modes of action: overview. Crit Rev Toxicol 33:581–9.
   PubMed Web of Science ®Google Scholar
• Corcos L, Berthou F. (2008). The CYP2B subfamily. In: Ioannides C, ed. Cytochromes P450. Role in the metabolism and toxicity of drugs and other xenobiotics. Cambridge: RSC. p. 178–99.
   Google Scholar
• Crunkhorn SE, Plant KE, Gibson GG, Kramer K, Lyon J, Lord PG, Plant NJ. (2004). Gene expression changes in rat liver following exposure to liver growth agents: role of Kupffer cells in xenobiotic-mediated liver growth. Biochem Phamacol 67:107–18.
   PubMed Web of Science ®Google Scholar
• de la Iglesia FA, McGuire EJ, Haskins JR, Lalwani ND. (1996). Structural diversity of peroxisome proliferators and their effects on mammalian liver cells in vivo. Ann NY Acad Sci 804:310–27.
   PubMedGoogle Scholar
• Dickins M. (2004). Induction of cytochromes P450. Curr Topics Med Chem 4:1745–66.
   PubMed Web of Science ®Google Scholar
• Diwan BA, Henneman JR, Rice JM, Nims RW. (1996). Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B. Carcinogenesis 17:37–43.
   PubMed Web of Science ®Google Scholar
• Diwan BA, Lubet RA, Ward JM, Hrabie JA, Rice JM. (1992). Tumor promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine. Carcinogenesis 13:1893–901.
   PubMedGoogle Scholar
• Diwan BA, Ward JM, Anderson LM, Hagiwara A, Rice JM. (1986). Lack of effect of phenobarbital on hepatocellular carcinogenesis initiated by N-nitrosodiethylamine or methylazoxymethanol acetate in male Syrian golden hamsters. Toxicol Appl Pharmacol 86:298–307.
   PubMed Web of Science ®Google Scholar
• Doull J, Cattley R, Elcombe C, Lake BG, Swenberg J., Wilkinson C, Williams G, van Gemert M. (1999). A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Regul Toxicol Pharmacol 29:327–57.
   PubMed Web of Science ®Google Scholar
• Durnford JM, Brody RS, Hejtmancik MR, Kurtz PJ, Renne RA, Gideon KM, Marsman DS. (1995). Differential enzyme inducing activity of peroxisome proliferators in the male Syrian hamster. Int Toxicol 7: 47-P-4.
   Google Scholar
• Dutton DR, McMillen SK, Parkinson A. (1988). Induction of cytochrome P-450 by phenobarbital and 3-methylcholanthrene: differences between rats and hamsters. Toxicologist 8(1):8.
   Google Scholar
• Eacho PI, Foxworthy PS, Johnson WD, Hoover DM, White SL. (1986). Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species. Toxicol Appl Pharmacol 83:430–7.
   PubMed Web of Science ®Google Scholar
• Eacho PL, Lanier TL, Brodhecker CA. (1991). Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis 12:1557–61.
   PubMed Web of Science ®Google Scholar
• Edwards RJ, Price RJ, Watts PS, Renwick AB, Tredger JM, Boobis AR, Lake BG. (2003). Induction of cytochrome P450 enzymes in cultured precision-cut human liver slices. Drug Metab Dispos 31:282–8.
   PubMed Web of Science ®Google Scholar
• Elcombe CR, Bell DR, Elias E, Hasmall SC, Plant NJ. (1996). Peroxisome proliferators: species differences in response of primary hepatocyte cultures. Ann NY Acad Sci 804:628–35.
   PubMedGoogle Scholar
• Eldridge SR, Tilbury LF, Goldsworthy TL, Butterworth BE. (1990). Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2′-deoxyuridine and [3H]thymidine administered by injection or osmotic pump. Carcinogenesis 11:2245–51.
   PubMed Web of Science ®Google Scholar
• Fidaleo M. (2009). Human health risk assessment for peroxisome proliferators: more than 30 years of research. Exptl Toxicol Pathol 61:215–21.
   PubMedGoogle Scholar
• Foster JR. (2000). Cell death and cell proliferation in the control of normal and neoplastic tissue growth. Toxicol Pathol 28:441–6.
   PubMed Web of Science ®Google Scholar
• Galloway SM, Johnson TE, Armstrong MJ, Ashby J. (2000). The genetic toxicology of the peroxisome proliferator class of rodent hepatocarcinogen. Mutat Res 448:153–8.
   PubMedGoogle Scholar
• Garcia-Allan C, Loughlin J, Orton T, Lord P. (1997). Changes in protein and mRNA levels of growth factor/growth factor receptors in rat livers after administration of phenobarbitone and methylclofenapate. Arch Toxicol 71:409–15.
   PubMedGoogle Scholar
• Gerbal-Chaloin S, Pascussi J-M, Pichard-Garcia L, Daujat M, Waechter F, Fabre J-M, Carrère N, Maurel P. (2001). Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos 29:242–51.
   PubMed Web of Science ®Google Scholar
• Gibson GG. (1989). Comparative aspects of the mammalian cytochrome P450 IV gene family. Xenobiotica 19:1123–48.
   PubMed Web of Science ®Google Scholar
• Gibson GG. (1993). Peroxisome proliferators: paradigms and prospects. Toxicol Lett 68:193–201.
   PubMed Web of Science ®Google Scholar
• Gibson GG. (1996). Peroxisome proliferators and cytochrome P4504A induction. Ann NY Acad Sci 804:328–40.
   PubMedGoogle Scholar
• Gibson GG, Orton TC, Tamburini PP. (1982). Cytochrome P-450 induced by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). Biochem J 203:161–8.
   PubMed Web of Science ®Google Scholar
• Gill JH, James NH, Roberts RA, Dive C. (1998). The non-genotoxic carcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFβ1, DNA damage and Fas. Carcinogenesis 19:299–304.
   PubMedGoogle Scholar
• Gold LS, Manley NB, Slone TH, Ward JM. (2001). Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol. Pathol. 29:639–52.
   PubMed Web of Science ®Google Scholar
• Goldsworthy TL, Fransson-Steen R. (2002). Quantitation of the cancer process in C57BL/6J, B6C3F1 and C3H/HeJ mice. Toxicol Pathol 20:97–105.
   Google Scholar
• Goll V, Alexandre E, Viollon-Abadie C, Nicod L, Jaeck D, Richert L. (1999). Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures. Toxic Appl Pharmacol 160:21–32.
   PubMedGoogle Scholar
• Gonzalez FJ, Shah YM. (2008). PPARα: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators. Toxicology 246:2–8.
   PubMed Web of Science ®Google Scholar
• Gooding PE, Chayen J, Sawyer B, Slater TF. (1978). Cytochrome P-450 distribution in rat liver and the effect of sodium phenobarbitone administration. Chem Biol Interact 20:299–310.
   PubMed Web of Science ®Google Scholar
• Graham MJ, Lake BG. (2008). Induction of drug metabolism: species differences and toxicological relevance. Toxicology 254:184–91.
   PubMed Web of Science ®Google Scholar
• Graham MJ, Wilson SA, Winham MA, Spencer AJ, Rees JA, Old SL, Bonner FW. (1994). Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for 3 years. Fund Appl Toxicol 22:58–64.
   PubMedGoogle Scholar
• Graham RA, Goodwin B, Merrihew RV, Krol WL, LeCluyse EL. (2006). Cloning, tissue expression, and regulation of Beagle dog CYP4A genes. Toxicol Sci 92:356–67.
   PubMedGoogle Scholar
• Grasso P, Hinton RH. (1991). Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liver. Mutat Res 248:271–90.
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Dudley CN, Cunningham ML. (1996) Biochemical effects of the mouse hepatocarcinogen oxazepam: similarities to phenobarbital. Fund Appl Toxicol 29:147–54.
   PubMedGoogle Scholar
• Hagiwara A, Miyata E, Tamano S, Sano M, Masuda C, Funae Y, Ito N, Fukushima S, Shirai T. (1999). Non-carcinogenicity, but dose-related increase in preneoplastic hepatocellular lesions, in a two-year feeding study of phenobarbital sodium in male F344 rats. Food Chem Toxicol 37:869–79.
   PubMedGoogle Scholar
• Hasmall SC, James NH, Macdonald N, Gonzalez FJ, Peters JM, Roberts RA. (2000). Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARα and TNFα. Mutat Res 448:193–200.
   PubMedGoogle Scholar
• Hasmall SC, James NH, Soames AR, Roberts RA. (1998). The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro. Arch Toxicol 72:777–83.
   PubMedGoogle Scholar
• Hasmall SC, Roberts RA. (1999). The perturbation of apoptosis and mitosis by drugs and xenobiotics. Pharmacol Ther 82:63–70.
   PubMed Web of Science ®Google Scholar
• Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. (2005). Role of peroxisome proliferator-activated receptor-α (PPARα) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis 26:219–27.
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, LeCluyse EL, Ferguson SS. (2007). Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro–in vivo correlations. Xenobiotica 37:1196–224.
   PubMed Web of Science ®Google Scholar
• Hirose Y, Nagahori N, Yamada T, Deguchi Y, Tomigahara Y, Nishioka K, Uwagawa S, Kawamura S, Isobe N, Lake BG, Okuno Y. (2009). Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes. Toxicology 258:64–9.
   PubMed Web of Science ®Google Scholar
• Hoivik DJ, Qualls CW Jr, Mirabile RC, Cariello NF, Kimbrough CL, Colton HM, Anderson SP, Santostefano MJ, Ott Morgan RJ, Dahl RR, Brown AR, Zhao Z, Mudd PN Jr, Oliver WB Jr, Brown HR, Miller RT. (2004). Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys. Carcinogenesis 25:1757–69.
   PubMed Web of Science ®Google Scholar
• Holsapple MP, Pitot HC, Cohen SH, Boobis AR, Klaunig JE, Pastoor T, Dellarco VL, Dragan YP. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci 89:51–6.
   PubMed Web of Science ®Google Scholar
• Honkakoski P, Negishi M. (2000). Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 347:321–37.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang J, Washington M, Liu J, Parant JM, Lozano G, Moore DD. (2005). Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol 19:1646–53.
   PubMed Web of Science ®Google Scholar
• Huff J, Cirvello J, Haseman J, Bucher J. (1991). Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ Health Perspect 93:247–70.
   PubMed Web of Science ®Google Scholar
• Iida M, Anna CH, Hartis J, Bruno M, Wetmore B, Dubin JR, Sieber S, Bennett L, Cunningham ML, Paules RS, Tomer KB, Houle CD, Merrick AB, Sills RC, Devereux TR. (2003) Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis 24:757–70.
   PubMed Web of Science ®Google Scholar
• Imaoka S, Osada M, Minamiyama Y, Yukimura T, Toyokuni S, Takemura S, Hiroi T, Funae Y. (2004). Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett 203:117–25.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer (IARC). (2001). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 79. Some thyrotropic agents. Lyon: IARC Press.
   Google Scholar
• Ioannides C. (2008). Cytochromes P450: role in the metabolism and toxicity of drugs and other xenobiotics. Cambridge: RSC.
   Google Scholar
• James NH, Roberts RA. (1994). The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes. Carcinogenesis 15:2687–94.
   PubMed Web of Science ®Google Scholar
• James NH, Roberts RA. (1995). Species differences in the clonal expansion of hepatocytes in response to the coaction of epidermal growth factor and nafenopin, a hepatocarcinogenic peroxisome proliferator. Fundam Appl Toxicol 26:143–9.
   PubMedGoogle Scholar
• James NH, Roberts RA. (1996). Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. Carcinogenesis 17:1623–32.
   PubMed Web of Science ®Google Scholar
• Jones CR, Lubet RA. (1992). Induction of a pleiotropic response by phenobarbital and related compounds. Response of various inbred strains of rats, response in various species and the induction of aldehyde dehydrogenase in Copenhagen rats. Biochem Pharmacol 44:1651–60.
   PubMedGoogle Scholar
• Jones HB, Orton TC, Lake BG. (2009). Effect of chronic phenobarbitone administration on liver tumour formation in the C57BL/10J mouse. Food Chem Toxicol 47:1333–40.
   PubMed Web of Science ®Google Scholar
• Kamendulis LM, Isenberg JS, Smith JH, Pugh G Jr, Lington AW, Klaunig JE. (2002). Comparative effects of phthalate monoesters on gap junctional intercellular communication and peroxisome proliferation in rodent and primate hepatocytes. J Toxicol Environ Health 65:569–88.
   PubMed Web of Science ®Google Scholar
• Kamendulis LM, Kolaja KL, Stevenson DE, Walborg EF Jr, Klaunig JE. (2001). Comparative effects of dieldrin on hepatic ploidy, cell proliferation, and apoptosis in rodent liver. J Toxicol Environ Health 62:127–41.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, DeLuca JG, Lai DY, McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA. (2003). PPARa agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol 33:655–780.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Ruch RJ, Weghorst CM. (1990). Comparative effects of phenobarbital, DDT, and lindane on mouse hepatocyte gap junctional intercellular communication. Toxicol Appl Pharmacol 102:553–63.
   PubMed Web of Science ®Google Scholar
• Kolaja KL, Stevenson DE, Johnson JT, Walborg EF Jr, Klaunig JE. (1996a). Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam Appl Toxicol 29:219–28.
   PubMedGoogle Scholar
• Kolaja KL, Stevenson DE, Johnson JT, Walborg EF Jr, Klaunig JE. (1996b). Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis 17:947–54.
   PubMed Web of Science ®Google Scholar
• Koufaris C, Wright J, Currie R, Gooderham NJ. (forthcoming 2009). Carcinogenic and non-carcinogenic doses of phenobarbital cause distinct microRNA profiles in male Fischer rats after 14 days of dietary exposure. Poster presentation at the British Toxicology Annual Congress 2009. Toxicology.
   Google Scholar
• Kraupp-Grasl B, Huber W, Taper H, Schulte-Hermann R. (1991). Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci. Cancer Res 51:666–71.
   PubMed Web of Science ®Google Scholar
• Lake BG. (1995). Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annu Rev Pharmacol Toxicol 35:483–507.
   PubMed Web of Science ®Google Scholar
• Lake BG, Evans JG, Cunninghame ME, Price RJ. (1993) Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster. Environ Health Perspect 101 (Suppl. 5):241–7.
   PubMedGoogle Scholar
• Lake BG, Evans JG, Gray TJB, Körösi SA, North CJ. (1989). Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig and marmoset. Toxicol Appl Pharmacol 99:148–60.
   PubMed Web of Science ®Google Scholar
• Lake BG, Gray TJB, Foster JR, Stubberfield CR, Gangolli SD. (1984b). Comparative studies on di-(2-ethylhexyl)phthalate-induced hepatic peroxisome proliferation in the rat and hamster. Toxicol Appl Pharmacol 72:46–60.
   PubMed Web of Science ®Google Scholar
• Lake BG, Gray TJB, Pels Rijcken WR, Beamand J, Gangolli SD. (1984a). The effect of hypolipidaemic agents on peroxisomal β-oxidation and mixed-function oxidase activities in primary cultures of rat hepatocytes. Relationship between induction of palmitoyl-CoA oxidation and lauric acid hydroxylation. Xenobiotica 14:269–76.
   PubMed Web of Science ®Google Scholar
• Lake BG, Lewis DFV. (1996). The CYP4 family. In: Ioannnides C, ed. Cytochromes P450: metabolic and toxicological aspects. Boca Raton, FL: CRC Press. p. 271–97.
   Google Scholar
• Lake BG, Rumsby PC, Cunninghame ME, Price RJ. (2002). Dose-related effects of the peroxisome proliferator methylclofenapate in rat liver. Environ Toxicol Pharmacol 11:233–42.
   PubMedGoogle Scholar
• Lake BG, Rumsby PC, Price RJ, Cunninghame ME. (2000). Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-β1 gene expression in the rat, Syrian hamster and guinea pig. Mutat Res 448:213–25.
   PubMedGoogle Scholar
• Lawrence JW, Li Y, Chen S, DeLuca JG, Berger JP, Umbenhauer DR, Moller DE, Zhou G. (2001). Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) α. PPARα fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression. J Biol Chem 276:31521–7.
   PubMed Web of Science ®Google Scholar
• Lee SS-T, Pineau T, Drago J, Lee EJ, Owens JW., Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. (1995). Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012–22.
   PubMed Web of Science ®Google Scholar
• Lehman-McKeeman LD, Caudill D, Vassallo JD, Fix AS. (1999). Increased spontaneous liver tumor susceptibility in cytochrome P450 2B1 (CYP2B1) transgenic mice. Toxicol Sci 48 (Suppl. 1):253.
   Google Scholar
• Lin JH. (2006). CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res 23:1089–116.
   PubMed Web of Science ®Google Scholar
• Makowska JM, Gibson GG, Bonner FW. (1992). Species differences in ciprofibrate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation. J Biochem Toxicol 7:183–91.
   PubMedGoogle Scholar
• Marsman DS, Cattley RC, Conway JG, Popp JA. (1988). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di-(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res 48:6739–44.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GMM, de Kanter R. (2006). Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2:875–94.
   PubMed Web of Science ®Google Scholar
• Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33:591–653.
   PubMed Web of Science ®Google Scholar
• Meredith C, Scott MP, Barton A, Price RJ, Hupp TR, Elcombe CR, Lake BG. (2004). Effect of furan, chloroform, di-(2-ethylhexyl)phthalate (DEHP) and oxazepam on biomarkers of cell cycling and proliferation in mouse liver. Toxicol Sci 78 (Suppl. 1):abstract 1716.
   Google Scholar
• Moore JT, Moore LB, Maglich JM, Kliewer SA. (2003). Functional and structural comparison of PXR and CAR. Biochim Biophys Acta 1619:235–8.
   PubMed Web of Science ®Google Scholar
• Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA. (2000). Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122–7.
   PubMed Web of Science ®Google Scholar
• Morimura K, Cheung C, Ward JM, Reddy JK, Gonzalez FJ. (2006). Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor α to Wy-14,463-induced liver tumorigenesis. Carcinogenesis 27:1074–80.
   PubMed Web of Science ®Google Scholar
• Neveu MJ, Babcock KL, Hertzberg EL, Paul DL, Nicholson BJ, Pitot HC. (1994). Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Cancer Res. 54:3145–52.
   PubMed Web of Science ®Google Scholar
• Nims RW, Devor DE, Henneman JR, Lubet RA. (1987). Induction of alkoxyresorufin O-dealkylases, epoxide hydrolase, and liver weight gain: correlation with liver tumor-promoting potential in a series of barbiturates. Carcinogenesis 8:67–71.
   PubMed Web of Science ®Google Scholar
• Nims RW, Lubet RA. (1995). Induction of cytochrome P-450 in the Norway rat, Rattus norvegicus, following exposure to potential environmental contaminants. J Toxicol Envionr Health 46:271–92.
   PubMed Web of Science ®Google Scholar
• Nims RW, Lubet RA. (1996). The CYP2B subfamily. In: Ioannides C, ed. Cytochromes P450: metabolic and toxicological aspects. Boca Raton, FL: CRC Press. p. 135–60.
   Google Scholar
• Olsen JH, Boice JD Jr, Jensen JPA, Fraumeni JF Jr. (1989). Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst 81:803–8.
   PubMed Web of Science ®Google Scholar
• Olsen JH, Schulgen G, Boice JD Jr, Whysner J, Travis LB, Williams GM, Johnson FB, McGee, JO’ D. (1995). Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res 55:294–7.
   PubMed Web of Science ®Google Scholar
• Orton TC, Adam HK, Bentley M, Holloway B, Tucker MJ. (1984). Clobuzarit: species differences in the morphological and biochemical response of the liver following chronic administration. Toxicol Appl Pharmacol 73:138–51.
   PubMed Web of Science ®Google Scholar
• Orton TC, Doughty SE, Kalinowski AE, Lord PG, Wadsworth PF. (1996). Expression of growth factors and growth factor receptors in the liver of C57BL/10J mice following administration of phenobarbitone. Carcinogenesis 17:973–81.
   PubMed Web of Science ®Google Scholar
• Osimitz TG, Lake BG. (forthcoming 2009). Mode of action analysis for induction of rat liver tumors by Pyrethrins: relevance to human cancer risk. Crit Rev Toxicol 39(6):501–11.
   Google Scholar
• Pacot C, Petit M, Rollin M, Behechti N, Moisant M, Deslex P, Althoff J, Lhuguenot JC, Latruffe N. (1996). Differences between guinea pig and rat in the liver peroxisome response to equivalent plasmatic level of ciprofibrate. Arch Biochem Biophys 327:181–8.
   PubMedGoogle Scholar
• Parke DV. (1968). The biochemistry of foreign compounds. Oxford: Pergamon.
   Google Scholar
• Parkinson A. (2001). Biotransformation of xenobiotics. In: Klaassen CD, ed. Casarett and Doull’s toxicology: the basic science of poisons. 6th Ed. New York, NY: McGraw Hill. p. 133−224.
   Google Scholar
• Parzefall W, Erber E, Sedivy R, Schulte-Hermann R. (1991). Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res 51:1143–7.
   PubMed Web of Science ®Google Scholar
• Pascussi J-M, Gerbal-Chaloin S, Drocourt L, Assénat E, Larrey D, Pichard-Garcia L, Vilarem M-J, Maurel P. (2004). Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences. Xenobiotica 34:633–64.
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Mäenpää J, Taavitsainen P, Rautio A, Raunio H. (1998). Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:1203–53.
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H. (2008). Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 82:667–715.
   PubMed Web of Science ®Google Scholar
• Perrone CE, Shao L, Williams GM. (1998). Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes. Toxicol Appl Pharmacol 150:277–86.
   PubMed Web of Science ®Google Scholar
• Peters JM, Aoyama T, Cattley RC, Nobumitsu U, Hashimoto T, Gonzalez FJ. (1998). Role of peroxisome proliferator-activated receptor α in altered cell cycle regulation in mouse liver. Carcinogenesis 19:1989–94.
   PubMed Web of Science ®Google Scholar
• Peters JM, Cattley RC, Gonzalez FJ. (1997). Role of PPARα in the mechanism of action of the non-genotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18:2029–33.
   PubMed Web of Science ®Google Scholar
• Phillips JC, Price RJ, Cunninghame ME, Osimitz TG, Cockburn A, Gabriel KL, Preiss F, Butler WH, Lake BG. (1997). Effect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats. Fundam Appl Toxicol 38:64–74.
   PubMedGoogle Scholar
• Pirttiaho HI, Sotaniemi E.A, Ahokas JT, Pitkänen U. (1978). Liver size and indices of drug metabolism in epileptics. Br J Clin Pharmacol 6:273–8.
   PubMed Web of Science ®Google Scholar
• Pirttiaho HI, Sotaniemi EA, Pelkonen RO, Pitkänen U. (1982). Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol 22:441–5.
   PubMed Web of Science ®Google Scholar
• Plant NJ, Horley NJ, Dickins M, Hasmall S, Elcombe CR, Bell DR. (1998). The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate. Carcinogenesis 19:1521–7.
   PubMedGoogle Scholar
• Price RJ, Evans JG, Lake BG. (1992) Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster. Food Chem Toxicol 30:937–44.
   PubMed Web of Science ®Google Scholar
• Pustylnyak VO, Lebedev AN, Gulyaeva LF, Lyakhovich VV, Slynko NM. (2007). Comparative study of CYP2B induction in the liver of rats and mice by different compounds. Life Sci 80:324–8.
   PubMed Web of Science ®Google Scholar
• Raucy JL, Lasker J, Ozaki K, Zoleta V. (2004). Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol Sci 79:233–41.
   PubMed Web of Science ®Google Scholar
• Reddy JK, Lalwani ND. (1983). Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit Rev Toxicol 12:1–58.
   Web of Science ®Google Scholar
• Rice JM, Diwan BA, Hu H, Ward JM, Nims RW, Lubet RA. (1994). Enhancement of hepatocarcinogenesis and induction of specific cytochrome P450-dependent monooxygenase activities by the barbiturates allobarbital, aprobarbital, pentobarbital, secobarbital and 5-phenyl- and 5-ethylbarbituric acids. Carcinogenesis 15:395–402.
   PubMedGoogle Scholar
• Richert L, Lamboley C, Viollon-Abadie C, Grass P, Hartmann N, Laurent S, Heyd B, Mantion G, Chibout S-D, Staedtler F. (2003). Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes. Toxicol Appl Pharmacol 191:130–46.
   PubMed Web of Science ®Google Scholar
• Richert L, Price S, Chesne C, Maita K, Carmichael N. (1996). Comparison of the induction of hepatic peroxisome proliferation by herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes. Toxicol Appl Pharmacol 141:35–43.
   PubMedGoogle Scholar
• Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE. (2007). Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96:2–15.
   PubMed Web of Science ®Google Scholar
• Roberts RA, Soames AR, Gill JH, James NH, Wheeldon EB. (1995). Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis 16:1693–8.
   PubMedGoogle Scholar
• Roglans N, Bellido A, Rodriguez C, Cabrero A, Novell F, Ros E, Zambón D, Laguna JC. (2002). Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver. Clin Pharmacol Ther 72:692–701.
   PubMed Web of Science ®Google Scholar
• Ross PK, Woods CG, Bradford BU, Kosyk O, Gatti DM, Cunningham ML, Rusyn I. (2009). Time-course comparison of xenobiotic activators of CAR and PPARα in mouse liver. Toxicol Appl Pharmacol 235:199–207.
   PubMedGoogle Scholar
• Schulte-Hermann R, Kraupp-Grasl B, Bursch W, Gerbracht U, Timmermann-Trosiener I. (1989). Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver. Toxicol Pathol 17:642–9.
   PubMedGoogle Scholar
• Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W. (1990). DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 50:5127–35.
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J. (1983). Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res 43:839–44.
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J. (1986). Facilitated expression of adaptive responses to phenobarbital in putative pre-stages of liver cancer. Carcinogenesis 7:1651–5.
   PubMedGoogle Scholar
• Shah YM, Morimura K, Yang Q, Tanabe T, Takagi M, Gonzalez F.J. (2007). Peroxisome proliferator-activated receptor α regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol Cell Biol 27:4238–47.
   PubMed Web of Science ®Google Scholar
• Sharma R, Lake BG, Foster J, Gibson GG. (1988). Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship. Biochem Pharmacol 37:1193–201.
   PubMed Web of Science ®Google Scholar
• Stenbäck F, Mori H, Furuya K, Williams GM. (1986). Pathogenesis of dimethylnitrosamine-induced hepatocellular cancer in hamster liver and lack of enhancement by phenobarbital. J Natl Cancer Inst 76:327–33.
   PubMedGoogle Scholar
• Styles JA, Kelly M, Pritchard NR, Elcombe CR. (1988). A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatocyte. Carcinogenesis 9:1647–55.
   PubMedGoogle Scholar
• Tanaka T, Mori H, Williams GM. (1987). Enhancement of dimethylnitrosamine-initiated hepatocarcinogenesis in hamsters by subsequent administration of carbon tetrachloride but not by phenobarbital or p,p′-dichlorodiphenyltrichoroethane. Carcinogenesis 8:1171–8.
   PubMed Web of Science ®Google Scholar
• Thorpe E, Walker AIT. (1973). The toxicology of dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, β-BHC and γ-BHC. Food Chem Toxicol 11:433–42.
   Google Scholar
• Tien ES, Negishi M. (2006). Nuclear receptors CAR and PXR in the regulation of hepatic metabolism. Xenobiotica 36:1152–63.
   PubMed Web of Science ®Google Scholar
• Tucker MJ, Orton TC. (1995). Comparative toxicology of hypolipidaemic fibrates. London: Taylor & Francis.
   Google Scholar
• Wada N, Marsman DS, Popp JA. (1992). Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication. Fund Appl Toxicol 18:149–54.
   PubMedGoogle Scholar
• Wang H, Faucette SR, Gilbert D, Jolley SL, Sueyoshi T, Negishi M, LeCluyse EL. (2003). Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. Drug Metab Dispos 31:620–30.
   PubMed Web of Science ®Google Scholar
• Wei P, Zhang J, Egan-Hafley M, Liang S, Moore DD. (2000). The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407:920–3.
   PubMed Web of Science ®Google Scholar
• Whysner J, Ross PM, Williams GM. (1996). Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71:153–91.
   PubMed Web of Science ®Google Scholar
• Woodyatt NJ, Lambe KG, Myers KA, Tugwood JG, Roberts RA. (1999). The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs. Carcinogenesis 20:369–72.
   PubMed Web of Science ®Google Scholar
• Yamada T, Uwagawa S, Okuno Y, Cohen SM, Kaneko H. (2009). Case study: an evaluation of the human relevance of the synthetic pyrethroid metofluthrin-induced liver tumors in rats based on mode of action. Toxicol Sci 108:59–68.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR. (2004). The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64:7197–200.
   PubMed Web of Science ®Google Scholar
• Yang Q, Nagano T, Shah Y, Cheung C, Ito S, Gonzalez FJ. (2008). The PPARα-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPARα. Toxicol Sci 101:132–9.
   PubMed Web of Science ®Google Scholar
• Yoshinari K, Tien E, Negishi M, Honkakoski P. (2008). Receptor-mediated regulation of cytochromes P450. In: Ioannides C, ed. Cytochromes P450: role in the metabolism and toxicity of drugs and other xenobiotics. Cambridge: RSC. p. 417–48.
   Google Scholar